These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 27211870)

  • 1. Complement in disease: a defence system turning offensive.
    Ricklin D; Reis ES; Lambris JD
    Nat Rev Nephrol; 2016 Jul; 12(7):383-401. PubMed ID: 27211870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The complement system-a "hot topic" not only for kidney diseases].
    Amann K; Daniel C; Büttner-Herold M
    Pathologe; 2020 May; 41(3):238-247. PubMed ID: 32240352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
    Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
    Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cells: source, barrier, and target of defensive mediators.
    Roumenina LT; Rayes J; Frimat M; Fremeaux-Bacchi V
    Immunol Rev; 2016 Nov; 274(1):307-329. PubMed ID: 27782324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self, non-self, and danger: a complementary view.
    Köhl J
    Adv Exp Med Biol; 2006; 586():71-94. PubMed ID: 16893066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement system: pathophysiology and clinical relevance.
    Speth C; Würzner R; Stoiber H; Dierich MP
    Wien Klin Wochenschr; 1999 May; 111(10):378-91. PubMed ID: 10413831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of complement in innate and autoimmunity.
    Seelen MA; Roos A; Daha MR
    J Nephrol; 2005; 18(6):642-53. PubMed ID: 16358221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel roles of complement in renal diseases and their therapeutic consequences.
    Wada T; Nangaku M
    Kidney Int; 2013 Sep; 84(3):441-50. PubMed ID: 23615508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the genetics of thrombotic microangiopathies.
    Vieira-Martins P; El Sissy C; Bordereau P; Gruber A; Rosain J; Fremeaux-Bacchi V
    Transfus Apher Sci; 2016 Apr; 54(2):212-9. PubMed ID: 27177491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N; Ayer M; Ergen A; Ozturk S
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement Activation in Progression of Chronic Kidney Disease.
    Chen SF; Chen M
    Adv Exp Med Biol; 2019; 1165():423-441. PubMed ID: 31399977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Benefits of Complement Measurements for the Clinical Practice.
    Grunenwald A; Roumenina LT
    Methods Mol Biol; 2021; 2227():1-20. PubMed ID: 33847926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ; Moliterno AR
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.
    Keragala CB; Draxler DF; McQuilten ZK; Medcalf RL
    Br J Haematol; 2018 Mar; 180(6):782-798. PubMed ID: 29265338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
    Sethi S; Fervenza FC
    Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.